Alia Therapeutics
ItalyEntry
2021
Hold
5yr
Status
Active
Who owns Alia Therapeutics?
Alia Therapeutics is an Italian Biotech company, currently owned by Sofinnova Partners since 2021 and Indaco Venture Partners SGR.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Indaco Venture Partners SGRIndaco BIO · 2022 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2021 · present
Sofinnova PartnersActive
2021 · present(5yr) · Sofinnova Telethon · 2016 · Life Sciences VC
More from Indaco BIO
Other portfolio companies in the same fund.
Finland
DenmarkMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Alia Therapeutics?
Alia Therapeutics is currently owned by Sofinnova Partners and Indaco Venture Partners SGR, through Indaco BIO, since 2021.
When did Sofinnova Partners and 1 other acquire Alia Therapeutics?
Sofinnova Partners and 1 other acquired Alia Therapeutics in 2021.
Who has owned Alia Therapeutics over time?
Alia Therapeutics has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Telethon · since 2021; Indaco Venture Partners SGR · via Indaco BIO · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue